Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

scientific article published in Nature Communications

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2018NatCo...9.4182M
P356DOI10.1038/S41467-018-06541-2
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/s41467-018-06541-2
P932PMC publication ID6180091
P698PubMed publication ID30305637

P50authorPaolo BoffettaQ3362604
Hans-Olov AdamiQ5542230
Kenneth OffitQ20732365
Edward L. GiovannucciQ20740896
Nilanjan ChatterjeeQ21526241
Paolo VineisQ25999450
Stephen ChanockQ27662321
Charles S ChungQ55089374
Vijai JosephQ56875726
Brian K LinkQ61054699
Jianqing ZhangQ63380882
Geffen KleinsternQ63380891
Brenda M BirmannQ64500274
W. Ryan DiverQ67470776
Rebecca D. JacksonQ72504541
Peter KraftQ77526208
Meredith YeagerQ28025162
Nathaniel RothmanQ28050622
Federico CanzianQ28360459
Amy HutchinsonQ28484160
Elisabete WeiderpassQ28606966
Mads MelbyeQ28759321
Lesley F TinkerQ85643662
Kari E NorthQ85938878
Ruth TravisQ86575888
Roel C H VermeulenQ87253566
Belynda HicksQ87645484
Bryan A BassigQ88161634
Lynn GoldinQ88453247
Zhaoming WangQ89154327
Wendy CozenQ89747098
Lindsay MortonQ89850825
Lauren R TerasQ89929955
Huihuang YanQ92182658
Nisha PradhanQ92182666
Alain MonnereauQ92530001
Susan L SlagerQ92530010
Paige M BracciQ92530013
Neil CaporasoQ107095573
Sonja BerndtQ109521956
Laurie BurrowsQ114374083
Tongzhang ZhengQ114384098
Jacques RibyQ114384163
Christine F. SkibolaQ114384164
Caroline BessonQ51845718
Mark P. PurdueQ30348331
Lenka ForetováQ30830691
Yolanda BenaventeQ30830754
Jacqueline ClavelQ30830766
Alexandra NietersQ30830777
Bengt GlimeliusQ30830855
Marc MaynadiéQ30831170
Andrew L FeldmanQ42397592
James R CerhanQ44432041
Anthony StainesQ45403266
Jonathan N HofmannQ46610322
Henrik HjalgrimQ47366802
Karin Ekström SmedbyQ47366815
Silvia de SanjoséQ47367042
Anne J. NovakQ38223816
Claire Melissa VajdicQ40510446
Akinyemi I OjesinaQ41519438
P2093author name stringElizabeth E Brown
Ju-Hyun Park
Qing Lan
Yawei Zhang
Stephen M Ansell
Mary L McMaster
Alex Smith
Nikolaus Becker
Richard K Severson
Paul Brennan
Bin Zhu
Lucia Conde
James McKay
Christine Mayr
Charles Lawrence
Shengchao Alfred Li
Ann Maria
Mervin M Fansler
Rebecca Montalvan
P2860cites workModel-based analysis of ChIP-Seq (MACS)Q21183902
Regulation of STAT3-mediated signaling by LMW-DSP2Q24320250
Dysregulated TCL1 promotes multiple classes of mature B cell lymphomaQ24540383
Inference of population structure using multilocus genotype dataQ24548114
A second generation human haplotype map of over 3.1 million SNPsQ24651939
MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expressionQ24683830
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.Q27851888
Widespread intronic polyadenylation diversifies immune cell transcriptomes.Q52715419
Polygenic susceptibility to breast cancer and implications for preventionQ78029012
Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasmsQ81350341
Principal components analysis corrects for stratification in genome-wide association studiesQ27860975
Vienna RNA secondary structure serverQ28131816
The protooncogene TCL1 is an Akt kinase coactivatorQ28138483
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaQ28248768
Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk familiesQ28262604
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataQ28266682
Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregationQ28277343
Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individualsQ28285016
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in SwedenQ28290841
Ral GTPases in tumorigenesis: emerging from the shadowsQ28294053
Chronic immune stimulation and subsequent Waldenström macroglobulinemiaQ28294893
Mosaic loss of chromosome Y is associated with common variation near TCL1AQ28393244
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityQ28509328
A long noncoding RNA mediates both activation and repression of immune response genesQ28509769
Negative regulation of Toll-like-receptor signaling by IRF-4.Q28587563
Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene PromotersQ28592966
A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeuticsQ28673956
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.Q50762836
Susceptibility loci associated with specific and shared subtypes of lymphoid malignanciesQ28943260
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemiaQ28943339
Common SNPs explain a large proportion of the heritability for human heightQ29547221
Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.Q31040364
A comprehensive analysis of 3' end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylationQ31112743
Population substructure and control selection in genome-wide association studiesQ33348644
The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.Q33492280
A reference panel of 64,976 haplotypes for genotype imputationQ33553419
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingQ33732485
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemiaQ33803072
Extensive variation in chromatin states across humansQ33823781
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectQ34137888
Regulation by 3'-Untranslated RegionsQ47884146
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directionsQ34360414
A high-resolution map of the three-dimensional chromatin interactome in human cellsQ34378943
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survivalQ34571216
Estimating missing heritability for disease from genome-wide association studiesQ34687621
MicroRNA miR-324-3p induces promoter-mediated expression of RelA geneQ35050493
Genomic inflation factors under polygenic inheritanceQ35108650
Two susceptibility loci identified for prostate cancer aggressivenessQ35575585
Estimation of effect size distribution from genome-wide association studies and implications for future discoveriesQ36191121
Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppressionQ36401055
DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functionsQ36604484
DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory responseQ36657472
Familial cosegregation of rare genetic variants with disease in complex disordersQ36686684
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4Q36949425
Ral GTPases and cancer: linchpin support of the tumorigenic platformQ37064855
A role for IRF4 in the development of CLL.Q37235687
Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expressionQ37309705
COSMIC: somatic cancer genetics at high-resolutionQ37556877
MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemia.Q37723475
The diverse roles of IRF4 in late germinal center B-cell differentiationQ38002486
Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignanciesQ38182355
MicroRNA-324 in Human Cancer: miR-324-5p and miR-324-3p Have Distinct Biological Functions in Human Cancer.Q38734850
Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C.Q38879351
2016 US lymphoid malignancy statistics by World Health Organization subtypesQ39400737
The Inescapable Influence of Noncoding RNAs in CancerQ39927058
TCL1 expression patterns in Waldenström macroglobulinemiaQ41192923
Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populationsQ41544357
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.Q42285217
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectsusceptibility locusQ62091149
P304page(s)4182
P577publication date2018-10-10
P1433published inNature CommunicationsQ573880
P1476titleTwo high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
P478volume9

Reverse relations

Q92507373Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial riskcites workP2860

Search more.